BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 273 found
  Current Search:  hemophilia: 273     

HTML
100%
Former surgeon general Koop honored for AIDS work
HANOVER, N.H.

(AP) Former Surgeon General Dr.

Everett Koop is being honored in New Hampshire for his work on HIV and AIDS awareness and prevention.

Koop on Wednesday will receive the 2010 Ryan White Distinguished Leadership Award from Indiana University's...

Laconia Citizen:  Mar 20 2010 10:20PM
Matching: hemophilia
Find similar documents
HTML
100%
Baxter International First Quarter 2010 Financial Results Conference Call
Let the jobs come to you!

Baxter International (NYSE:BAX) will host a quarterly conference call to discuss its first quarter 2010 financial results on Thursday, April 22, 2010, at 8:30 a.m!

Eastern Time (7:30 a.m.

Central Time).

To access the call,...

PharmiWeb:  Mar 20 2010 10:18PM
Matching: hemophilia
Find similar documents
HTML
100%
Baxter International First Quarter 2010 Financial Results Conference Call
DEERFIELD, Ill.-- (BUSINESS WIRE) -- Baxter International (NYSE:BAX) will host a quarterly conference call to discuss its first quarter 2010 financial results on Thursday, April 22, 2010, at 8:30 a.m.

Eastern Time (7:30 a.m.

Central Time).

To access the...

SmartBrief:  Mar 19 2010 4:07PM
Matching: hemophilia
Find similar documents
HTML
100%
Former surgeon general Koop honored for AIDS work
HANOVER, N.H.

(AP) Former Surgeon General Dr.

Everett Koop is being honored in New Hampshire for his work on HIV and AIDS awareness and prevention.

Koop on Wednesday will receive the 2010 Ryan White Distinguished Leadership Award from Indiana University's...

Foster's Daily Democrat:  Mar 18 2010 11:22PM
Matching: hemophilia
Find similar documents
HTML
100%
Former surgeon general Koop honored for AIDS work
HANOVER, N.H.

(AP) -- Former Surgeon General Dr.

Everett Koop is being honored in New Hampshire for his work on HIV and AIDS awareness and prevention.

Koop on Wednesday will receive the 2010 Ryan White Distinguished Leadership Award from Indiana...

WBZ NewsRadio 1030:  Mar 17 2010 11:57PM
Matching: hemophilia
Find similar documents
HTML
100%
Former surgeon general Koop honored for AIDS work
HANOVER, N.H.

(AP) - Former Surgeon General Dr.

Everett Koop is being honored in New Hampshire for his work on HIV and AIDS awareness and prevention.

Koop on Wednesday will receive the 2010 Ryan White Distinguished Leadership Award from Indiana University...

Fox41.com:  Mar 17 2010 11:54PM
Matching: hemophilia
Find similar documents
HTML
100%
Former surgeon general Koop honored for AIDS work
HANOVER, N.H.

(AP) - Former Surgeon General Dr.

Everett Koop is being honored in New Hampshire for his work on HIV and AIDS awareness and prevention.

Koop on Wednesday will receive the 2010 Ryan White Distinguished Leadership Award from Indiana University...

News 25:  Mar 17 2010 11:04AM
Matching: hemophilia
Find similar documents
HTML
100%
NewLife Homecare Partners With ChronoMed to Offer Customized Nutritional Program for Bleeding Disorder Community
PITTSTON, Pa., March 15 /PRNewswire/ -- NewLife Homecare, a leading specialty pharmacy serving people with bleeding disorders, is proud to introduce an innovative and highly-customized nutrition program for the bleeding disorder community.

The program, a...

Yahoo! Canada:  Mar 16 2010 6:46AM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Click the browser's refresh button to reload the requested page Click the browse Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B.
Montana's News Station:  Mar 15 2010 11:05AM
Matching: hemophilia
Find similar documents
HTML
100%
NewLife Homecare Partners With ChronoMed to Offer Customized Nutritional Program for Bleeding Disorder Community
Companies mentioned in this article: NewLife Homecare PITTSTON, Pa., March 15 /PRNewswire/ -- NewLife Homecare, a leading specialty pharmacy serving people with bleeding disorders, is proud to introduce an innovative and highly-customized nutrition program for...
Freshnews.com:  Mar 15 2010 5:21PM
Matching: hemophilia
Find similar documents
HTML
100%
GTC Biotherapeutics to Webcast Corporate Presentation at the ROTH 22nd Annual OC Growth Stock Conference
- GTC Biotherapeutics, Inc.

(GTC, NASDAQ: GTCB) announced today that Geoffrey Cox, Ph.

D., GTC's Chairman and CEO, is scheduled to present on Wednesday, March 17, 2010 at 2:00 p.m.

during the ROTH 22nd Annual OC Growth Stock Conference.

The conference...

Pharma Live:  Mar 13 2010 2:08AM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Amsterdam Molecular Therapeutics announced that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously debilitating and potentially lethal disease.

Amsterdam, The...

PipelineReview:  Mar 12 2010 12:48AM
Matching: hemophilia
Find similar documents
HTML
100%
Start Of Phase I/II Gene Therapy Clinical Trial For Hemophilia B
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously...
Medical News Today:  Mar 11 2010 2:23PM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
/PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for ...
KSLA:  Mar 11 2010 1:49PM
Matching: hemophilia
Find similar documents
HTML
100%
Biogen Idec Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released
Refer to a friend 2010-03-11 08:17:13 - Biogen Idec Inc.

- Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com Biogen Idec Inc.

- Pharmaceuticals & Healthcare - Deals and Alliances...

PR inside:  Mar 11 2010 7:26AM
Matching: hemophilia
Find similar documents
HTML
100%
Medical News: Start Of Phase I/II Gene Therapy Clinical Trial For Hemophilia B
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously...
BioFind:  Mar 11 2010 2:47PM
Matching: hemophilia
Find similar documents
HTML
100%
GTC Biotherapeutics to Webcast Corporate Presentation at the ROTH 22nd Annual OC Growth Stock Conference
Let the jobs come to you!

GTC Biotherapeutics, Inc!

(?GTC?, NASDAQ: GTCB) announced today that Geoffrey Cox, Ph.

D., GTC?s Chairman and CEO, is scheduled to present on Wednesday, March 17, 2010 at 2:00 p.m.

during the ROTH 22nd Annual OC Growth Stock...

PharmiWeb:  Mar 11 2010 3:38PM
Matching: hemophilia
Find similar documents
HTML
100%
GTC Biotherapeutics to Webcast Corporate Presentation at the ROTH 22nd Annual OC Growth Stock Conference
FRAMINGHAM, Mass.-- (BUSINESS WIRE) -- GTC Biotherapeutics, Inc.

(GTC, NASDAQ: GTCB) announced today that Geoffrey Cox, Ph.D., GTCs Chairman and CEO, is scheduled to present on Wednesday, March 17, 2010 at 2:00 p.m.

during the ROTH 22nd Annual OC Growth...

SmartBrief:  Mar 11 2010 12:35AM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for ...
Pharma Live:  Mar 10 2010 7:47PM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
-- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously...
companiesandmarkets.com:  Mar 10 2010 6:30PM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously...
Charlotte Business Journal:  Mar 10 2010 2:17PM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously...
Twin Cities Business Journal:  Mar 10 2010 2:12PM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously...
Austin Business Journal:  Mar 10 2010 1:57PM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously...
Twin Cities Business Journal:  Mar 10 2010 1:48PM
Matching: hemophilia
Find similar documents
HTML
100%
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously...
Kansas City Business Journal:  Mar 10 2010 1:38PM
Matching: hemophilia
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.